link
Bookmarks
 (0)
Gastrointestinal
Diagnosis
Liver
Inflammation
Steatosis and Steatohepatitis
Steatosis and Steatohepatitis
Michael P. Federle, MD, FACR
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
0
25
2
19

KEY FACTS

  • Terminology

    • Imaging

      • Top Differential Diagnoses

        • Pathology

          • Clinical Issues

            TERMINOLOGY

            • Synonyms

              • Hepatic steatosis or hepatic fatty metamorphosis
              • Nonalcoholic steatohepatitis (NASH)

            • Definitions

              • Characterized by accumulation of increasing amounts of triglycerides within hepatocytes
              • Steatosis is metabolic complication of variety of toxic, ischemic, and infectious insults to liver

            IMAGING

            • General Features

              • CT Findings

                • MR Findings

                  • Ultrasonographic Findings

                    • Nuclear Medicine Findings

                      • Imaging Recommendations

                        DIFFERENTIAL DIAGNOSIS

                          PATHOLOGY

                          • General Features

                            • Gross Pathologic & Surgical Features

                              • Microscopic Features

                                CLINICAL ISSUES

                                • Presentation

                                  • Demographics

                                    • Natural History & Prognosis

                                      • Treatment

                                        DIAGNOSTIC CHECKLIST

                                        • Consider

                                          • Image Interpretation Pearls

                                            Selected References

                                            1. Castera L et al: Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 156(5):1264-81.e4, 2019
                                            2. Flisiak-Jackiewicz M et al: Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children. Clin Exp Hepatol. 5(1):11-21, 2019
                                            3. Gu J et al: Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol. 29(7):3564-73, 2019
                                            4. Manka P et al: Fibrosis in chronic liver disease: an update on diagnostic and treatment Modalities. Drugs. 79(9):903-27, 2019
                                            5. Marchisello S et al: Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview. Int J Mol Sci. 20(8), 2019
                                            6. Zhou JH et al: Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice. World J Gastroenterol. 25(11):1307-26, 2019
                                            7. Zhang Y et al: Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. Br J Radiol. 91(1091):20170587, 2018
                                            8. Middleton MS et al: Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology. 153(3):753-61, 2017
                                            9. Chang W et al: Liver fibrosis staging with MR elastography: comparison of diagnostic performance between patients with chronic hepatitis B and those with other etiologic causes. Radiology. 280(1):88-97, 2016
                                            10. Idilman IS et al: Hepatic steatosis: etiology, patterns, and quantification. Semin Ultrasound CT MR. 37(6):501-10, 2016
                                            11. Karanjia RN et al: Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol. 22(45):9880-97, 2016
                                            12. Pais TP et al: Multiple liver lesions of unusual benign etiology mimicking metastatic disease. Gastroenterology. 147(2):e10-1, 2014
                                            13. Zoppini G et al: Mortality from chronic liver diseases in diabetes. Am J Gastroenterol. 109(7):1020-5, 2014
                                            14. Raptis DA et al: MRI: the new reference standard in quantifying hepatic steatosis? Gut. 61(1):117-27, 2012
                                            15. Lazo M et al: Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ. 343(7832):d6891, 2011
                                            16. Lee SS et al: Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease. J Magn Reson Imaging. 33(6):1390-8, 2011
                                            17. Mansour S et al: Non-alcoholic steatohepatitis mimicking liver metastasis in obesity surgery. Dig Endosc. 23(4):316-8, 2011
                                            18. Marsman HA et al: Hepatic steatosis assessment with CT or MRI in patients with colorectal liver metastases after neoadjuvant chemotherapy. J Surg Oncol. 104(1):10-6, 2011
                                            19. Rastogi A et al: Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol. 54(3):454-9, 2011
                                            20. Kalra N et al: Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 8(1):21-5, 2009
                                            21. Ma X et al: Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics. 29(5):1253-77, 2009
                                            22. Cowin GJ et al: Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging. 28(4):937-45, 2008
                                            23. Furlan A et al: Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study. AJR Am J Roentgenol. 191(5):1430-5, 2008
                                            24. Jou J et al: Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 28(4):370-9, 2008
                                            25. Park SH et al: Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 239(1):105-12, 2006
                                            26. Kemper J et al: CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging. 27(6):708-10, 2002
                                            27. Rubaltelli L et al: Targetlike appearance of pseudotumors in segment IV of the liver on sonography. AJR Am J Roentgenol. 178(1):75-7, 2002
                                            28. Outwater EK et al: Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance. Radiographics. 18(6):1465-80, 1998
                                            Related Anatomy
                                            Loading...
                                            Related Differential Diagnoses
                                            Loading...
                                            References
                                            Tables

                                            Tables

                                            KEY FACTS

                                            • Terminology

                                              • Imaging

                                                • Top Differential Diagnoses

                                                  • Pathology

                                                    • Clinical Issues

                                                      TERMINOLOGY

                                                      • Synonyms

                                                        • Hepatic steatosis or hepatic fatty metamorphosis
                                                        • Nonalcoholic steatohepatitis (NASH)

                                                      • Definitions

                                                        • Characterized by accumulation of increasing amounts of triglycerides within hepatocytes
                                                        • Steatosis is metabolic complication of variety of toxic, ischemic, and infectious insults to liver

                                                      IMAGING

                                                      • General Features

                                                        • CT Findings

                                                          • MR Findings

                                                            • Ultrasonographic Findings

                                                              • Nuclear Medicine Findings

                                                                • Imaging Recommendations

                                                                  DIFFERENTIAL DIAGNOSIS

                                                                    PATHOLOGY

                                                                    • General Features

                                                                      • Gross Pathologic & Surgical Features

                                                                        • Microscopic Features

                                                                          CLINICAL ISSUES

                                                                          • Presentation

                                                                            • Demographics

                                                                              • Natural History & Prognosis

                                                                                • Treatment

                                                                                  DIAGNOSTIC CHECKLIST

                                                                                  • Consider

                                                                                    • Image Interpretation Pearls

                                                                                      Selected References

                                                                                      1. Castera L et al: Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 156(5):1264-81.e4, 2019
                                                                                      2. Flisiak-Jackiewicz M et al: Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children. Clin Exp Hepatol. 5(1):11-21, 2019
                                                                                      3. Gu J et al: Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol. 29(7):3564-73, 2019
                                                                                      4. Manka P et al: Fibrosis in chronic liver disease: an update on diagnostic and treatment Modalities. Drugs. 79(9):903-27, 2019
                                                                                      5. Marchisello S et al: Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview. Int J Mol Sci. 20(8), 2019
                                                                                      6. Zhou JH et al: Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice. World J Gastroenterol. 25(11):1307-26, 2019
                                                                                      7. Zhang Y et al: Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. Br J Radiol. 91(1091):20170587, 2018
                                                                                      8. Middleton MS et al: Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology. 153(3):753-61, 2017
                                                                                      9. Chang W et al: Liver fibrosis staging with MR elastography: comparison of diagnostic performance between patients with chronic hepatitis B and those with other etiologic causes. Radiology. 280(1):88-97, 2016
                                                                                      10. Idilman IS et al: Hepatic steatosis: etiology, patterns, and quantification. Semin Ultrasound CT MR. 37(6):501-10, 2016
                                                                                      11. Karanjia RN et al: Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol. 22(45):9880-97, 2016
                                                                                      12. Pais TP et al: Multiple liver lesions of unusual benign etiology mimicking metastatic disease. Gastroenterology. 147(2):e10-1, 2014
                                                                                      13. Zoppini G et al: Mortality from chronic liver diseases in diabetes. Am J Gastroenterol. 109(7):1020-5, 2014
                                                                                      14. Raptis DA et al: MRI: the new reference standard in quantifying hepatic steatosis? Gut. 61(1):117-27, 2012
                                                                                      15. Lazo M et al: Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ. 343(7832):d6891, 2011
                                                                                      16. Lee SS et al: Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease. J Magn Reson Imaging. 33(6):1390-8, 2011
                                                                                      17. Mansour S et al: Non-alcoholic steatohepatitis mimicking liver metastasis in obesity surgery. Dig Endosc. 23(4):316-8, 2011
                                                                                      18. Marsman HA et al: Hepatic steatosis assessment with CT or MRI in patients with colorectal liver metastases after neoadjuvant chemotherapy. J Surg Oncol. 104(1):10-6, 2011
                                                                                      19. Rastogi A et al: Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol. 54(3):454-9, 2011
                                                                                      20. Kalra N et al: Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 8(1):21-5, 2009
                                                                                      21. Ma X et al: Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics. 29(5):1253-77, 2009
                                                                                      22. Cowin GJ et al: Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging. 28(4):937-45, 2008
                                                                                      23. Furlan A et al: Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study. AJR Am J Roentgenol. 191(5):1430-5, 2008
                                                                                      24. Jou J et al: Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 28(4):370-9, 2008
                                                                                      25. Park SH et al: Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 239(1):105-12, 2006
                                                                                      26. Kemper J et al: CT and MRI findings of multifocal hepatic steatosis mimicking malignancy. Abdom Imaging. 27(6):708-10, 2002
                                                                                      27. Rubaltelli L et al: Targetlike appearance of pseudotumors in segment IV of the liver on sonography. AJR Am J Roentgenol. 178(1):75-7, 2002
                                                                                      28. Outwater EK et al: Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance. Radiographics. 18(6):1465-80, 1998
                                                                                      Contact UsStoreTerms and ConditionsRegistered User AgreementPrivacy PolicyHelp